Skip to main content

Find Clinical Trials

Home
Conditions
Opioid-use Disorder

Clinical trial condition

Opioid-use Disorder

Explore clinical trials studying Opioid-use Disorder. Study availability and eligibility vary by location and protocol.

200 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Opioid-use Disorder trial results

Completed

Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment

NCT04308694

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: Health Park Pharmacy Raleigh, North Carolina, United States

Morse Clinic of North Raleigh Raleigh, North Carolina, United States

Morse Clinic of Zebulon Zebulon, North Carolina, United States

View Trial Details

Completed

SMART Trial: Community Stigma Reduction

NCT05075330

Conditions: Behavior, Chemically-Induced Disorders, Mental Disorders, +7 more
Locations: University of Tennessee Health Science Center Memphis, Tennessee, United States

View Trial Details

Completed

Single Ascending Dose Study of ALA-1000

NCT04122755

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: Innovative Clinical Research Miami, Florida, United States

View Trial Details

Completed

Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment

NCT04056182

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: STARS/NYSPI-Columbia University New York, United States

View Trial Details

Completed

Evaluating Adaptive Dispenser Initiation Protocols for MySafeRx During Post-detox Buprenorphine Treatment- a Pilot Study

NCT04449744

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: ACTS Adult Addiction Receiving Facility (AARF) Tampa, Florida, United States

View Trial Details

Completed

Quantitative Sensory Psychophysical Correlates of Pain in Pregnant Women With OUD

NCT04888962

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
Locations: University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

The Effect of Self-Forgiveness on Self-Stigma in Addiction.

NCT03971097

Conditions: Alcohol Abuse, Alcohol Use Disorder, Alcohol Withdrawal, +26 more
Locations: UPMC McKeesport McKeesport, Pennsylvania, United States

View Trial Details

Completed

Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

NCT04731935

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
Locations: Recovery Unplugged Austin, Texas, United States

View Trial Details

Completed

Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

NCT04075214

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
Locations: Recovery Unplugged Austin, Texas, United States

View Trial Details

Completed

Technology for MAT in Primary Care - Phase 1

NCT05006846

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: UCLA Center for Behavioral and Addiction Medicine Los Angeles, California, United States

View Trial Details